News
Updates from the healthcare landscape and the impact of Algocyte.
Oxford Immune Algorithmics Secures £5.1m To Advance Remote Health Monitoring And Precision Medicine
Drawing on more than a decade of research in computational biology and systems medicine conducted at institutions such as the the University of Oxford…
Mou Signing Ceremony Between Khawarizmi International College & Oxford Immune Algorithmics
Oxford Immune Algorithmics (OIA) is honoured to announce a new partnership with a major university in the UAE, Khawarizmi International College or KIC, made possible by Dr Assem Al-Hajj…
OIA Is Accepted Into The Spinlab’s Prestigious Accelerating Programme
SpinLab, one of the best-ranked accelerating programmes in Europe based in Leipzig, Germany, has selected a handful of startups out of hundreds of applications, including OIA, to be supported and introduced…
OIA’s New Branch Office In Abu Dhabi, U.A.E.
Supported by HUB71, a new subsidiary of OIA, Immune Algorithmics Middle East Ltd, has officially started operations and opened an office in Abu Dhabi.
OIA Is Accepted Into The ‘Cdl-recovery’ Programme In Atlanta, U.s. To Help The World Bounce Back
OIA has been accepted into the ‘CDL-recovery’ programme in Atlanta, U.S. with the purpose to explore the U.S. market and contribute to the world recovery during and after COVID-19.
The Impact Of Covid19 On Patients With Chronic Diseases
Most global healthcare resources are focused on COVID19 and this is largely disrupting the continuum of care for patients with chronic diseases (Chudasama et al., 2020).
Why Use Algocyte?*
Algocyte is helping change how frequently and where people are monitored and get tested, but most people (89%) are still at high risk of infection from travelling…
OIA Members Deliver Invited Talk On Oia’s Cutting-edge A.i. At Automata 2020
IA’s CTO Dr. Jürgen Riedel and Senior AI Researcher Dr. Santiago Hernández-Orozco delivered an invited technical talk at the international conference AUTOMATA 2020, the 26th International Workshop on Cellular…
OIA Is a Gold Sponsor of Automata 2020
AUTOMATA 2020 will focus on the theory and applications that many of OIA’s own proprietary methods are based upon, on the deep connections of discrete dynamical systems complexity…
OIA Is Nominated for the Best Start-up Medtech Award 2020 by Obn
OIA has been nominated to the OBN awards for the Best Start-up Medtech in the UK. The awards celebrate outstanding achievement throughout the life sciences industry.
Oxford Immune Algorithmics Is Now a Cogx 2020 Sponsor With a Virtual Booth
OIA has become a sponsor and will join CogX 2020 as an exhibitor with a dedicated virtual booth. CogX is the Festival of AI and Emerging Technology and will take place on the 8th-10th June 2020.
Oxford Immune Algorithmics Is Awarded a Grant to Explore Applications of Automata to Areas of Causation and Machine Intelligence
The FQXi catalyses, supports, and disseminates research on questions at the foundations of physics, particularly new frontiers and innovative ideas integral to a deep understanding of reality.
OIA Presenting Its Responsible AI Technology at the Predictive Analytics World Summit
Our CEO, Dr. Hector Zenil, will be delivering the opening Keynote at the Predictive Analytics World summit on May 11, 2020 originally planned to be held in Munich, Germany but now to be held online.
OIA Invited To Pitch Algocyte® At Sthlm Tech
According to the organisers, STHLM TECH is the largest startup event in Europe where every geek, hacker, entrepreneur, investor, and designer around Stockholm comes together under one roof.
OIA, Algocyte & Covid-19
Oxford Immune Algorithmics (OIA), like almost every other company and organisation around the world is putting in place contingency plans to downsize operations…
SFC And Kin Capital Join OIA As Investors With Joint Funds From The British Business Bank
We have successfully closed our latest funding round with SFC and KIN Capital leading it, award winning investors, both joining last week our multinational shareholder’s board supporting OIA.
Oxford Immune Algorithmics Is Chosen As One Of The 50 Most Promising Game-changers In The Thames Valley In The Uk
Oxford Immune Algorithmics (OIA) has been chosen one of 50 game-changers in the Thames Valley (UK’s Silicon Valley) for the creation of Algocyte and our responsible AI approaches…
Oxford Immune Algorithmics Partners With The University Of Reading To Support Their Local Internship Scheme
Oxford Immune Algorithmics (OIA) is very proud to have partnered with the University of Reading and welcomes two of their students in Computer Science hired with the partial support of the University of Reading…
Algocyte® Achieves CE Certification As A Medical Device
We are very excited to share the announcement that we have accomplished a major milestone getting Algocyte® certified under the European Commission medical device directive.
OIA Sponsors & Exhibits At Intelligent Health UK In London
OIA will be exhibiting at one of the world’s leading summits on AI in medicine, Intelligent Health 2020 on 5 February 2020 at a prime venue, the ExCel, London, U.K. where we will be promoting Algocyte, our flagship product for end-to-end remote blood testing…